Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Journal of Medicinal Chemistry
|
July 10, 1992
Synthesis and X-ray crystallographic analysis of quinazolinone cholecystokinin/gastrin receptor ligands
M J Yu, J R McCowan, N R Mason, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 1, 1981
Substituted piperazines as central serotonin agonists: comparative specificity of the postsynaptic actions of quipazine and m-trifluoromethylphenylpiperazine
R W Fuller, H D Snoddy, N R Mason, et al.
Journal of Medicinal Chemistry
|
October 1, 1989
Substituted 5-amino-4,5,6,7-tetrahydroindazoles as partial ergoline structures with dopaminergic activity
L A McQuaid, J E Latz, J A Clemens, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1985
Pharmacological activity of the isomers of LY53857, potent and selective 5-HT2 receptor antagonists
M L Cohen, K D Kurz, N R Mason, et al.
Research Communications in Chemical Pathology and Pharmacology
|
August 1, 1992
Inhibition of [3H]-MK801 binding and protection against NMDA-induced lethality in mice by a series of imipramine analogs
L A McQuaid, J D Leander, L G Mendelsohn, et al.
European Journal of Pharmacology
|
May 17, 1991
Species differences in affinities of non-peptide antagonists for substance P receptors
B D Gitter, D C Waters, R F Bruns, et al.
Journal of Medicinal Chemistry
|
August 1, 1988
Ergolines as selective 5-HT1 agonists
J S Ward, R W Fuller, L Merritt, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1988
Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067
M L Cohen, R W Fuller, K D Kurz, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1995
Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonist
B D Gitter, R F Bruns, J J Howbert, et al.
Journal of Medicinal Chemistry
|
August 1, 1983
Resolution and absolute configuration of an ergoline-related dopamine agonist, trans-4,4a,5,6,7,8,8a,9-Octahydro-5-propyl-1H(or 2H)-pyrazolo[3,4-g]quinoline
R D Titus, E C Kornfeld, N D Jones, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Journal of Medicinal Chemistry
|
July 10, 1992
Synthesis and X-ray crystallographic analysis of quinazolinone cholecystokinin/gastrin receptor ligands
M J Yu, J R McCowan, N R Mason, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 1, 1981
Substituted piperazines as central serotonin agonists: comparative specificity of the postsynaptic actions of quipazine and m-trifluoromethylphenylpiperazine
R W Fuller, H D Snoddy, N R Mason, et al.
Journal of Medicinal Chemistry
|
October 1, 1989
Substituted 5-amino-4,5,6,7-tetrahydroindazoles as partial ergoline structures with dopaminergic activity
L A McQuaid, J E Latz, J A Clemens, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1985
Pharmacological activity of the isomers of LY53857, potent and selective 5-HT2 receptor antagonists
M L Cohen, K D Kurz, N R Mason, et al.
Research Communications in Chemical Pathology and Pharmacology
|
August 1, 1992
Inhibition of [3H]-MK801 binding and protection against NMDA-induced lethality in mice by a series of imipramine analogs
L A McQuaid, J D Leander, L G Mendelsohn, et al.
European Journal of Pharmacology
|
May 17, 1991
Species differences in affinities of non-peptide antagonists for substance P receptors
B D Gitter, D C Waters, R F Bruns, et al.
Journal of Medicinal Chemistry
|
August 1, 1988
Ergolines as selective 5-HT1 agonists
J S Ward, R W Fuller, L Merritt, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1988
Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067
M L Cohen, R W Fuller, K D Kurz, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1995
Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonist
B D Gitter, R F Bruns, J J Howbert, et al.
Journal of Medicinal Chemistry
|
August 1, 1983
Resolution and absolute configuration of an ergoline-related dopamine agonist, trans-4,4a,5,6,7,8,8a,9-Octahydro-5-propyl-1H(or 2H)-pyrazolo[3,4-g]quinoline
R D Titus, E C Kornfeld, N D Jones, et al.
Page
of 4